COVID-19 EHS Resources

Here is information on disinfecting your work areas:

While Facility Services will continue to provide custodial services across campus, the need for more frequent cleaning means that each person on campus is expected to assist with cleaning their work spaces and possibly cleaning high touch point locations in their common spaces.  Please refer to the information below for guidance in how to accomplish this. Thank you for helping to "Protect the Pride". 

Cleaning Supplies

Facility Services will continue to supply cleaning supplies for classrooms, offices and common areas. 

Place a workorder for the cleaning supplies that you need.  Many of these items will not be charged to your department, even though you will need to enter your speedtype to complete the work order, it will be charged to the COVID-19 speedtype by Facility Services..

Personal Protective Equipment, etc.

Facility Services has much of the PPE (gloves, N95 mask, disposable masks, and face shields) on hand.  Place a workorder for the personal protective equipment that you need.  Many of these items will not be charged to your department, even though you will need to enter your speedtype to complete the work order, it will be charged to the COVID-19 speedtype by Facility Services. If Facility Services is unable to complete your request, they will contact you.

Disinfecting Poster

This is a poster that you can post in your area to remind individuals of types of things that are high touch point and require more frequent disinfecting.

Instructional Video

RESEARCH INVOLVING COVID-19

Research involving the Virus

The NIH Office of Science Policy has issued Frequently Asked Questions (FAQs) regarding interim biosafety guidance for research with SARS-CoV-2 and relevant Institutional Biosafety Committee (IBC) requirements under the NIH Guidelines.

Appendix B of the NIH Guidelines provides the basis for the classification of biohazardous agents by Risk Group (RG). At the present time, SARS-CoV-2 best meets the definition of a RG3 agent and IBCs should consider the agent to be RG3 as a starting point in their risk assessments when reviewing research subject to the NIH Guidelines.

The RG classification may change over time as additional information about the virus, such as potential treatments or the development of an effective vaccine, becomes available.

Questions about this guidance or other requirements under the NIH Guidelines may be addressed to NIHGuidelines@od.nih.gov.